Progress of the Share Repurchase Program
dsm-firmenich, a leader in nutrition, health, and beauty innovation, is making significant strides with its share repurchase program. Initially announced at €1 billion, this program is designed to effectively manage the company’s capital structure while supporting its commitment to shareholder returns.
Overview of the Repurchase Program
The program commenced in early April with an initial investment of €580 million. This included a specific allocation of €80 million intended for share-based compensation plans, while €500 million was slated for capital reduction. This strategic move positions dsm-firmenich to maintain robust shareholder value amidst market fluctuations.
Enhancements to the Program
On June 27, dsm-firmenich announced an increased program total of €1,080 million, thanks to the successful divestiture of its share in the Feed Enzymes Alliance. This adjustment reflects the company's proactive approach in adapting to its evolving financial landscape.
Recent Share Repurchases
From July 14 to July 18, dsm-firmenich reported the repurchase of 366,539 shares at an average price of €89.2, totaling €32.7 million. This brings the cumulative total of shares repurchased under the program to 4,895,048 shares at an average price of €93.5, resulting in an overall expenditure of €457.5 million.
Projected Completion Date
The company has earmarked January 30, 2026, as the deadline for the completion of this extensive share repurchase initiative. This timeline demonstrates dsm-firmenich's commitment to following through with shareholder value enhancement initiatives.
Corporate Strategy and Vision
dsm-firmenich stands at the forefront of delivering innovative solutions that address the nutritional and beauty needs of a growing global population. The company operates across almost 60 countries and achieves annual revenues exceeding €12 billion. With approximately 30,000 employees, the organization fosters an environment focused on sustainable development and scientific innovation.
Commitment to Stakeholders
Through this share repurchase program, dsm-firmenich not only seeks to provide immediate benefits to shareholders but also to ensure long-term sustainable growth. Capital management strategies are critical as the company continues to align its objectives with market demands and shareholder expectations.
Contact Information
For further inquiries, stakeholders are encouraged to reach out to dsm-firmenich's investor relations or media teams via the following email addresses:
Investor Relations: investors@dsm-firmenich.com
Media Inquiries: media@dsm-firmenich.com
Frequently Asked Questions
What is the purpose of the share repurchase program?
The share repurchase program aims to manage capital effectively while enhancing shareholder value through strategic buybacks.
How much has dsm-firmenich spent on share repurchases so far?
As of now, dsm-firmenich has spent approximately €457.5 million to repurchase nearly 4.9 million shares.
When is the share repurchase program expected to finish?
The completion deadline for the share repurchase program is set for January 30, 2026.
What impact does the program have on shareholders?
The repurchase program is designed to increase shareholder returns and support the company's overall financial strategy.
Who can I contact for more information?
For any inquiries regarding the program, you can contact dsm-firmenich's investor or media relations teams via email.
